A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
about
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammalsThe BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatmentFounder mutations in the BRCA1 gene in Polish families with breast-ovarian cancerFounder populations and their uses for breast cancer genetics.Identification of a founder BRCA2 mutation in SardiniaBRCA1 and BRCA2 mutations in central and southern Italian patients.Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancerBRCA2 mutation carriers, reproductive factors and breast cancer riskBRCA1 and BRCA2 mutations in a population-based study of male breast cancerThe Icelandic founder mutation BRCA2 999del5: analysis of expressionHigh proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaGenetics and biology of pancreatic ductal adenocarcinomaA rare variant in MYH6 is associated with high risk of sick sinus syndromeMale breast cancer in Cowden syndrome patients with germline PTEN mutationsGermline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian PopulationTumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutationBest practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium.Molecular technology and pancreatic cancer.Analysis of Swedish male breast cancer family data: a simple way to incorporate a common sibling effect.Origin and distribution of the BRCA2-8765delAG mutation in breast cancerNovel de novo BRCA2 mutation in a patient with a family history of breast cancerFive recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian populationPancreatic adenocarcinoma: epidemiology and genetics.An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genesA population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer DatabaseClinicopathological study of male breast carcinoma: 24 years of experience.The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination?Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage ConsortiumClinical management of BRCA1- and BRCA2-associated breast cancer.Inherited predisposition to pancreatic cancer.Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations.Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.
P2860
Q22010135-61B8E603-0A81-4EB1-8211-983136B55331Q24310211-A8297FD9-6077-48A6-902D-0D427072890FQ24540270-D8DB07B7-1F07-4386-A836-228C4247F418Q24544179-D71A4EC1-77E8-41DE-A1CC-BB9433982EF3Q24649532-E457BF5C-3540-414E-9745-D577987F23E2Q24791292-F519F98A-C960-483B-8404-E3AFAEE313CFQ24796354-E0A99FD7-48EF-4BE4-94B7-FDF4C8DFB346Q24803237-69EA33EB-00DB-407D-A6AF-A2A70AE49F74Q24803673-5CA195DF-1B00-4711-A660-B25B2FBE72FCQ24805817-998A7A26-EA76-4F7F-96AF-91FB206F1E19Q24813558-D04242FD-FDA9-4306-ABD5-31232168932FQ26765438-96D11BB4-2782-48B8-9521-1DB6B407AC0FQ28306661-6DE6AFB1-BC32-4261-B5A3-3C10EFDDEF9DQ28359884-E6A38863-6E3A-4F2F-90CF-A4DA2AA104A5Q28389268-2B7BB5E5-623A-4D8B-BFEF-F93E35E491F1Q28586360-BBB5B76A-76F0-4337-B5BE-7D41109F410DQ30418185-E4ED2774-6C94-4074-A817-CD99F990434CQ31800438-DE7B23F0-A300-4DC5-B274-371ADCDC7419Q32066874-4DB31466-B5A6-4994-8C0F-8297323B20EAQ33291268-8DA9642D-D751-46C2-B71C-3D4097705AA6Q33348765-0B3A0015-BA6B-4823-8BDF-17210F1AB63BQ33368443-8C5AB9D0-4D6E-4BC9-8BBE-C6186F6E78AFQ33454990-22F57647-472F-4554-B01C-0EA229854EEEQ33484437-9DB0F552-9184-451F-ADDC-AC8201B6C622Q33677968-BFB7D2B3-BB1D-4E8E-80C7-067F8022B720Q33679990-899CC2EC-5146-4922-93F4-398AFBDBB762Q33680173-C4E7E4A7-7C9A-4405-BDFF-5DE075D43A32Q33680801-D5F2B61A-9291-45D5-A7FB-35E277EBA60EQ33684029-D316CABC-4B2D-48E4-A00D-2094C85090E5Q33732336-9FC09D4A-77B1-4A79-A4B3-89D53F4A9790Q33738278-07674269-827A-4FBD-A867-83AC4210C6F1Q33867563-1B88AA8B-F9DF-4964-AC06-4D51FFDAF070Q33894527-9D15CDB4-33ED-47A2-8F29-721CC3A0FFF7Q33915589-62BD3C87-980A-407C-812D-99F372783A8CQ33931174-B4D54FA0-3A1D-4728-8ED8-9EBB1653A4F4Q33933643-1B33914F-639B-4BB7-8DA4-3BF4DE3AA328Q33964990-101D245F-DF86-4F6A-AAB2-7E074F16625FQ34065253-482C74A8-0DC6-4AA4-8E12-D62E1AC98C1AQ34080597-014F117A-BA0B-410A-B69B-AFE2EBA37BC5Q34145680-A018733D-EDBB-48D7-A1AA-1DE1B38CCA79
P2860
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@ast
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@en
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@nl
type
label
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@ast
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@en
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@nl
prefLabel
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@ast
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@en
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@nl
P2093
P2860
P356
P1433
P1476
A single BRCA2 mutation in mal ...... with varied cancer phenotypes.
@en
P2093
Eyfjörd JE
Jonasson JG
Ogmundsdottir HM
Olafsdottir G
Tavtigian SV
Thorlacius S
Tulinius H
P2860
P2888
P304
P356
10.1038/NG0596-117
P407
P577
1996-05-01T00:00:00Z